BMG LABTECH - the Microplate Reader Company - Celebrates 25 Successful Years
News Jan 27, 2015
Starting as an engineering office in Offenburg, Germany BMG LABTECH has become one of the world’s leading manufacturers of microplate readers with subsidiaries in Australia, France, Japan, UK, and the USA. The introduction of the FLUOstar® microplate reader helped BMG LABTECH to its breakthrough and brought the company to the forefront of detection technology. Since then, the company with its headquarters and production in Germany has developed a wide range of dedicated and multimode microplate readers for life science applications and high-throughput screening.
Over the years, BMG LABTECH has always been at the frontline of microplate reader technology, offering several innovative features such as fluorescence polarization, laser-based nephelometry, Simultaneous Dual Emission detection, and a high resolution ultra-fast UV/Vis spectrometer. With its latest device, the CLARIOstar® multimode microplate reader, the company offers unique and revolutionary LVF monochromators™ which provide filter-like performance and increased sensitivity over conventional monochromators. The LVF monochromators™, along with filters and a UV/ Vis spectrometer, can be used for a variety of applications in up to eight different detection modes. Thanks to its new Atmospheric Control Unit, the CLARIOstar® is now even able to provide the physiological environment for any cell type, enhancing cell-based microplate assays.
BMG LABTECH’s devices offer many types of bioanalytical measurement techniques including fluorescence intensity, fluorescence polarization, luminescence, time-resolved fluorescence, UV/Vis absorbance, AlphaScreen®, and nephelometry. All microplate readers are manufactured and tested at BMG LABTECH’s headquarters in Germany, which guarantees their precision, reliability, and robustness. BMG LABTECH continuously works with all of the leading reagent companies to handle the increasingly challenging requirements of popular microplate assays.
BMG LABTECH owes 25 years expertise in microplate reading technology not least to the long employment of high-skilled staff with the company. An open, team-oriented corporate culture, characterized by a strong relationship of trust and cooperative dealing in the company, ensures a low labor turnover rate and a high level of employee satisfaction. Today, BMG LABTECH has 55 employees at its headquarters in Germany. Another 50 employees offer a worldwide sales and support network with offices in Australia, France, Japan, UK and the United States.
Worms Exhibit Fear and Respond to Anti-anxiety MedsNews
A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
New Drug Compounds Help Prevent Hearing LossNews
Researchers from St. Jude Children's Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.READ MORE